CN112022899A - 一种中药复合粉的制备方法 - Google Patents
一种中药复合粉的制备方法 Download PDFInfo
- Publication number
- CN112022899A CN112022899A CN202010743625.2A CN202010743625A CN112022899A CN 112022899 A CN112022899 A CN 112022899A CN 202010743625 A CN202010743625 A CN 202010743625A CN 112022899 A CN112022899 A CN 112022899A
- Authority
- CN
- China
- Prior art keywords
- mass
- parts
- chinese medicine
- traditional chinese
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 27
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 239000000843 powder Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 15
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 15
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 15
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 15
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 15
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 15
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241001529821 Agastache Species 0.000 claims abstract description 14
- 241001162994 Rugosus Species 0.000 claims abstract description 14
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims abstract description 14
- 239000011550 stock solution Substances 0.000 claims abstract description 14
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000004140 cleaning Methods 0.000 claims abstract description 8
- 239000011669 selenium Substances 0.000 claims abstract description 8
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 7
- 150000001413 amino acids Chemical class 0.000 claims abstract description 7
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 7
- 239000011575 calcium Substances 0.000 claims abstract description 7
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims abstract description 7
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims abstract description 7
- 235000019797 dipotassium phosphate Nutrition 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 7
- 239000000796 flavoring agent Substances 0.000 claims abstract description 7
- 235000019634 flavors Nutrition 0.000 claims abstract description 7
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 claims abstract description 7
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 claims abstract description 7
- 229940099596 manganese sulfate Drugs 0.000 claims abstract description 7
- 235000007079 manganese sulphate Nutrition 0.000 claims abstract description 7
- 239000011702 manganese sulphate Substances 0.000 claims abstract description 7
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 235000013379 molasses Nutrition 0.000 claims abstract description 7
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims abstract description 7
- 235000019796 monopotassium phosphate Nutrition 0.000 claims abstract description 7
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims abstract description 7
- 235000015067 sauces Nutrition 0.000 claims abstract description 7
- 238000007789 sealing Methods 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 7
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 12
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 6
- 241000194031 Enterococcus faecium Species 0.000 claims description 6
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 6
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 6
- 229930003451 Vitamin B1 Natural products 0.000 claims description 6
- 229930003471 Vitamin B2 Natural products 0.000 claims description 6
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 6
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 6
- 229960002477 riboflavin Drugs 0.000 claims description 6
- 229960003495 thiamine Drugs 0.000 claims description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 6
- 235000010374 vitamin B1 Nutrition 0.000 claims description 6
- 239000011691 vitamin B1 Substances 0.000 claims description 6
- 235000019164 vitamin B2 Nutrition 0.000 claims description 6
- 239000011716 vitamin B2 Substances 0.000 claims description 6
- 235000019158 vitamin B6 Nutrition 0.000 claims description 6
- 239000011726 vitamin B6 Substances 0.000 claims description 6
- 229940011671 vitamin b6 Drugs 0.000 claims description 6
- 238000000034 method Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 230000003647 oxidation Effects 0.000 abstract description 4
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 230000002087 whitening effect Effects 0.000 abstract description 4
- 240000004510 Agastache rugosa Species 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Toxicology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种中药复合粉的制备方法，所述方法包括以下步骤，S1、将艾草和藿香洗净后干燥，粉碎至50‑150目；S2、取菌体原液与艾草和藿香粉碎物1:1混合搅拌；S3、依次加入质量份数为2‑50份的复合VB(2‑50kg)、20‑80份的糖蜜、0.2‑2.5份的磷酸二氢钾、0.15‑2.5份的磷酸氢二钾、0.15‑1份的七水硫酸镁、0.2‑5份的复合氨基酸、0.05‑1份的磷酸氢钙、0.005‑0.05份的硫酸锰、0.001‑0.1份的ATP和0.005‑0.05份有机硒；S4、装袋密封后放室内25‑40℃环境温度中发酵1个月，产品有明显酱香味道为发酵后成品。本发明制得的中药粉兼具排毒、祛湿、细胞修复、美白和抗氧化等功效。
Description
技术领域
本发明涉及保健品技术领域，具体涉及一种中药复合粉的制备方法。
背景技术
随着人们日常生活的进步，出现了很多新的保健方式，足浴就是其中一种，现代中医认为，人的双脚上存在着与各脏腑器官相对应的反射区，当用温水泡脚时，可以刺激这些反射区，人体通过清洁双脚，不仅可以去污除臭，还可以促进人体血液循环，调理内分泌系统，平衡人体阴阳、清内火、宁心神、降低血液粘稠度和血脂，进而有效提高人体免疫力。
足浴粉作为足浴过程中添加的药物保健品，通常由中草药制成，可有效提高足浴的保健效果，现有的足浴粉通常功能单一，一般只有缓解疲劳的功能，无法同时做到排毒、祛湿、细胞修复、美白和抗氧化等功效。
发明内容
本发明所要解决的问题是：提供一种中药复合粉的制备方法，通过本发明制得的中药粉兼具排毒、祛湿、细胞修复、美白和抗氧化等功效。
本发明为解决上述问题所提供的技术方案为：一种中药复合粉的制备方法，所述方法包括以下步骤，
S1、将艾草和藿香洗净后干燥，粉碎至50-150目；
S2、取菌体原液与艾草和藿香粉碎物1:1混合搅拌；
S3、依次加入质量份数为2-50份的复合VB(2-50kg)、20-80份的糖蜜、0.2-2.5份的磷酸二氢钾、0.15-2.5份的磷酸氢二钾、0.15-1份的七水硫酸镁、0.2-5份的复合氨基酸、0.05-1份的磷酸氢钙、0.005-0.05份的硫酸锰、0.001-0.1份的ATP和0.005-0.05份有机硒；
S4、装袋密封后放室内25-40℃环境温度中发酵1个月，产品有明显酱香味道为发酵后成品。
优选的，所述菌体原液为嗜酸乳杆菌、嗜热链球菌、屎肠球菌中的一种或者多种结合。
优选的，所述复合VB包括维生素B1、维生素B2、维生素B6中的一种或多种。
与现有技术相比，本发明的优点是：
1、本发明的制备步骤中加入的艾草和藿香使得制得的中药粉具有排毒和祛湿的作用；
2、本发明的制备步骤中加入的复合VB和有机硒使得制得的中药粉具有细胞修复和抗氧化的作用，能够有效的消除人体内的自由基；
3、本发明的制备步骤中加入的菌体原液所产生的各类酶和有机酸成分使得制得的中药粉具有美白的效果，使得脚部的皮肤更加细腻；
4、本发明在制备过程中通过发酵实现细胞破壁，使得各组分中的有效成分充分的发挥出来，制得的中药粉的药效更好。
具体实施方式
以下将通过具体实施例来详细说明本发明的实施方式，借此对本发明如何应用技术手段来解决技术问题并达成技术功效的实现过程能充分理解并据以实施。
实施例1
一种中药复合粉的制备方法，所述方法包括以下步骤，
S1、将艾草和藿香洗净后干燥，粉碎至50目；
S2、取菌体原液与艾草和藿香粉碎物各500KG混合搅拌；
S3、依次加入2kg复合VB、20-80份的糖蜜、0.2kg磷酸二氢钾、0.15kg磷酸氢二钾、0.15kg七水硫酸镁、0.2kg复合氨基酸、0.05kg磷酸氢钙、0.005kg硫酸锰、0.001kgATP和0.005kg有机硒；
S4、装袋密封后放室内25-40℃环境温度中发酵1个月，产品有明显酱香味道为发酵后成品。
所述菌体原液为嗜酸乳杆菌、嗜热链球菌、屎肠球菌中的一种或者多种结合。
所述复合VB包括维生素B1、维生素B2、维生素B6中的一种或多种。
实施例2
一种中药复合粉的制备方法，所述方法包括以下步骤，
S1、将艾草和藿香洗净后干燥，粉碎至70目；
S2、取菌体原液与艾草和藿香粉碎物各500KG混合搅拌；
S3、依次加入8kg复合VB、40kg的糖蜜、1kg磷酸二氢钾、0.8kg磷酸氢二钾、0.3kg七水硫酸镁、0.3kg复合氨基酸、0.1kg磷酸氢钙、0.01kg硫酸锰、0.01kgATP和0.01kg有机硒；
S4、装袋密封后放室内25-40℃环境温度中发酵1个月，产品有明显酱香味道为发酵后成品。
所述菌体原液为嗜酸乳杆菌、嗜热链球菌、屎肠球菌中的一种或者多种结合。
所述复合VB包括维生素B1、维生素B2、维生素B6中的一种或多种。
实施例3
一种中药复合粉的制备方法，所述方法包括以下步骤，
S1、将艾草和藿香洗净后干燥，粉碎至100目；
S2、取菌体原液与艾草和藿香粉碎物各500KG混合搅拌；
S3、依次加入30kg复合VB、40kg糖蜜、105kg磷酸二氢钾、1.5kg磷酸氢二钾、0.8kg七水硫酸镁、2kg复合氨基酸、0.8kg磷酸氢钙、0.03kg硫酸锰、0.08kgATP和0.02kg有机硒；
S4、装袋密封后放室内25-40℃环境温度中发酵1个月，产品有明显酱香味道为发酵后成品。
所述菌体原液为嗜酸乳杆菌、嗜热链球菌、屎肠球菌中的一种或者多种结合。
所述复合VB包括维生素B1、维生素B2、维生素B6中的一种或多种。
实施例4
一种中药复合粉的制备方法，所述方法包括以下步骤，
S1、将艾草和藿香洗净后干燥，粉碎至150目；
S2、取菌体原液与艾草和藿香粉碎物各500KG混合搅拌；
S3、依次加入50kg复合VB、80kg糖蜜、2.5kg磷酸二氢钾、2.5kg磷酸氢二钾、1kg七水硫酸镁、5kg复合氨基酸、1kg磷酸氢钙、0.05kg硫酸锰、0.1kgATP和0.05kg有机硒；
S4、装袋密封后放室内25-40℃环境温度中发酵1个月，产品有明显酱香味道为发酵后成品。
所述菌体原液为嗜酸乳杆菌、嗜热链球菌、屎肠球菌中的一种或者多种结合。
所述复合VB包括维生素B1、维生素B2、维生素B6中的一种或多种。
本发明的中药粉还可以做成膏状外敷在皮肤上。
以上仅就本发明的最佳实施例作了说明，但不能理解为是对权利要求的限制。本发明不仅局限于以上实施例，其具体结构允许有变化。凡在本发明独立权利要求的保护范围内所作的各种变化均在本发明保护范围内。
Claims (3)
1.一种中药复合粉的制备方法，其特征在于：所述方法包括以下步骤，
S1、将艾草和藿香洗净后干燥，粉碎至50-150目；
S2、取菌体原液与艾草和藿香粉碎物1:1混合搅拌；
S3、依次加入质量份数为2-50份的复合VB、20-80份的糖蜜、0.2-2.5份的磷酸二氢钾、0.15-2.5份的磷酸氢二钾、0.15-1份的七水硫酸镁、0.2-5份的复合氨基酸、0.05-1份的磷酸氢钙、0.005-0.05份的硫酸锰、0.001-0.1份的ATP和0.005-0.05份有机硒；
S4、装袋密封后放室内25-40℃环境温度中发酵1个月，产品有明显酱香味道为发酵后成品。
2.根据权利要求1所述的一种中药复合粉的制备方法，其特征在于：所述菌体原液为嗜酸乳杆菌、嗜热链球菌、屎肠球菌中的一种或者多种结合。
3.根据权利要求1所述的一种中药复合粉的制备方法，其特征在于：所述复合VB包括维生素B1、维生素B2、维生素B6中的一种或多种。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010743625.2A CN112022899A (zh) | 2020-07-29 | 2020-07-29 | 一种中药复合粉的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010743625.2A CN112022899A (zh) | 2020-07-29 | 2020-07-29 | 一种中药复合粉的制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112022899A true CN112022899A (zh) | 2020-12-04 |
Family
ID=73583476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010743625.2A Pending CN112022899A (zh) | 2020-07-29 | 2020-07-29 | 一种中药复合粉的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112022899A (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103766604A (zh) * | 2014-01-16 | 2014-05-07 | 北京百丰天下生物科技有限公司 | 一种复合益生菌制剂的制备 |
| CN110101760A (zh) * | 2019-05-15 | 2019-08-09 | 山西大学 | 一种外用中草药及其液态发酵工艺 |
-
2020
- 2020-07-29 CN CN202010743625.2A patent/CN112022899A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103766604A (zh) * | 2014-01-16 | 2014-05-07 | 北京百丰天下生物科技有限公司 | 一种复合益生菌制剂的制备 |
| CN110101760A (zh) * | 2019-05-15 | 2019-08-09 | 山西大学 | 一种外用中草药及其液态发酵工艺 |
Non-Patent Citations (1)
| Title |
|---|
| SEVEN的瑜伽世界: "养生泡脚:艾草+广藿香 祛湿排毒一身轻", 《HTTPS://WWW.XIAOHONGSHU.COM/DISCOVERY/ITEM/5E8495E800000000010008BA》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101965971B (zh) | 核桃火麻油保健食品 | |
| CN106690199A (zh) | 一种活菌型功能果冻及其加工工艺 | |
| CN104957610B (zh) | 一种植物酵素及其制备方法和用途 | |
| CN106889414A (zh) | 双菌山楂固体饮料 | |
| CN101991095A (zh) | 一种改善睡眠的保健品 | |
| CN103156895A (zh) | 一种抗疲劳胶囊及其制备方法 | |
| CN107307129A (zh) | 一种具有益气固表保健功效的酵素饮品及其生产工艺 | |
| CN105962369A (zh) | 一种红茶酶解液制备乳酸菌发酵液的方法 | |
| CN106721449A (zh) | 一种肉鸡专用提高免疫力的饲料 | |
| CN105685972A (zh) | 具有减脂瘦身功能的益生菌组合物及其制备方法与应用 | |
| CN104839652A (zh) | 产妇产后调理医学配方食品 | |
| CN105639393A (zh) | 一种提高人体抗疲劳的人参益生菌食品 | |
| CN110463772A (zh) | 一种具有助睡眠与抗焦虑功能的酸奶及其制备方法 | |
| CN104187637A (zh) | 壮阳全营养配方食品 | |
| CN102783648A (zh) | 具有益智、益骨骼、益于儿童生长发育作用的功能食品及其制备方法 | |
| CN112022899A (zh) | 一种中药复合粉的制备方法 | |
| CN104839670A (zh) | 特禀体质医学配方食品 | |
| CN104839642A (zh) | 卵巢癌医学配方食品 | |
| CN106221989A (zh) | 一种保健葡萄酒的制作方法 | |
| CN109527308A (zh) | 一种具有调理肠胃功能的益生菌饮品及其制备方法 | |
| CN107495203A (zh) | 一种含山楂的离子维c组合物及其制备方法 | |
| CN104839671A (zh) | 壮阳医学配方食品 | |
| CN109007226A (zh) | 一种雨生红球藻虾青素果蔬酵素压片糖果及其制备方法 | |
| CN108813453A (zh) | 一种防治帕金森病的食用组合物 | |
| CN108402367A (zh) | 一种发酵人参维他命汽水的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201204 |
|
| RJ01 | Rejection of invention patent application after publication |